Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy Participants

Jason R. Harris, Aernout D. van Haarst, Jill Baccei, Bridgette Franey, Jason Everett, Kory George, Sabina Paglialunga, Kenneth Webster, Michelle Hillstrand, Chris Banfield, Thomas S. Scanlan, Gudarz Davar

Open source

DOI
10.1111/cts.70743
Published
2026-10-28
Container
Clinical and Translational Science
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.70743,
  title = {Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy Participants},
  author = {Jason R. Harris and Aernout D. van Haarst and Jill Baccei and Bridgette Franey and Jason Everett and Kory George and Sabina Paglialunga and Kenneth Webster and Michelle Hillstrand and Chris Banfield and Thomas S. Scanlan and Gudarz Davar},
  year = {2026},
  journal = {Clinical and Translational Science},
  doi = {10.1111/cts.70743},
  url = {https://doi.org/10.1111/cts.70743}
}

RIS

TY  - JOUR
TI  - Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy Participants
AU  - Jason R. Harris
AU  - Aernout D. van Haarst
AU  - Jill Baccei
AU  - Bridgette Franey
AU  - Jason Everett
AU  - Kory George
AU  - Sabina Paglialunga
AU  - Kenneth Webster
AU  - Michelle Hillstrand
AU  - Chris Banfield
AU  - Thomas S. Scanlan
AU  - Gudarz Davar
PY  - 2026
JO  - Clinical and Translational Science
DO  - 10.1111/cts.70743
UR  - https://doi.org/10.1111/cts.70743
ER  - 

APA

Harris, J. R., Haarst, A. D. V., Baccei, J., Franey, B., Everett, J., George, K., Paglialunga, S., Webster, K., Hillstrand, M., Banfield, C., Scanlan, T. S., & Davar, G. (2026). Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy Participants. Clinical and Translational Science. https://doi.org/10.1111/cts.70743

Source records